Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Lance PagliaroCurtis A Pettaway

Abstract

Men with penile squamous cell carcinoma and regional lymph node involvement have a low probability of survival with lymphadenectomy alone. A multimodal approach to treatment is desirable for such patients. We performed a phase II study of neoadjuvant chemotherapy with the objective of determining the response rate, time to progression (TTP), and overall survival (OS) among patients with bulky adenopathy. Eligible patients had stage N2 or N3 (stage III or stage IV) penile cancer without distant metastases. Neoadjuvant treatment (four courses every 3-4 weeks) consisted of paclitaxel 175 mg/m(2) administered over 3 hours on day 1; ifosfamide 1,200 mg/m(2) on days 1 to 3; and cisplatin 25 mg/m(2) on days 1 to 3. Clinical and pathologic responses were assessed, and patient groups were compared for TTP and OS. Thirty men received chemotherapy of whom 15 (50.0%) had an objective response and 22 (73.3%) subsequently underwent surgery. Three patients had no remaining tumor on histopathology. Nine patients (30.0%) remained alive and free of recurrence (median follow-up, 34 months; range, 14-59 months), and two patients died of other causes without recurrence. Improved TTP and OS were significantly associated with a response to chemothera...Continue Reading

References

May 1, 1987·The Journal of Urology·V SrinivasW F Whitmore
Nov 1, 1973·Cancer·J B de KernionJ P Fegen
Mar 1, 1993·The Journal of Urology·S HorenblasE W van Waardenburg
Apr 29, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D M ShinS M Lippman
Nov 10, 2000·International Journal of Radiation Oncology, Biology, Physics·G S MontanaH E Averette
Mar 31, 2004·The Lancet Oncology·Sanjeev MisraNaresh C Misra
Jan 21, 2006·Journal of Surgical Oncology·Durgatosh PandeyR Ravi Kannan
Feb 24, 2007·European Urology·Joost A P LeijteSimon Horenblas
Mar 10, 2007·Nature Clinical Practice. Urology·Giacomo NovaraVincenzo Ficarra
Apr 18, 2008·Annals of Oncology : Official Journal of the European Society for Medical Oncology·C TheodoreUNKNOWN EORTC Genito-Urinary Tract Cancer Group
Jul 9, 2008·World Journal of Urology·M C G BleekerC J L M Meijer
Jul 19, 2008·World Journal of Urology·Juanita CrookLaval Grimard
May 29, 2009·CA: a Cancer Journal for Clinicians·Ahmedin JemalMichael J Thun

❮ Previous
Next ❯

Citations

Jan 8, 2013·Der Urologe. Ausg. A·C Protzel, O W Hakenberg
Aug 5, 2011·International Urology and Nephrology·Jonathan E HeinlenDaniel Joseph Culkin
Jan 30, 2013·Chinese Journal of Cancer Research = Chung-kuo Yen Cheng Yen Chiu·Yao Zhu, Ding-Wei Ye
Nov 5, 2013·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·J-L DevilleC Bastide
Jan 8, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G SonpavdeG Di Lorenzo
Aug 27, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H Van PoppelUNKNOWN ESMO Guidelines Working Group
Apr 7, 2012·Anti-cancer Drugs·Pasquale RescignoGiuseppe Di Lorenzo
Jun 21, 2011·Advances in Urology·Samuel M LawindyPhilippe E Spiess
Jan 17, 2014·The New England Journal of Medicine·W Scott McDougalChin-Lee Wu
Sep 14, 2012·Cellular Oncology (Dordrecht)·Daniele MinardiGiovanni Muzzonigro
Jul 25, 2014·British Journal of Cancer·P-H ChiangY-C Shen
May 3, 2014·Clinical Genitourinary Cancer·Gregory R PondGuru Sonpavde
Nov 18, 2014·Case Reports in Oncological Medicine·Arpit ChhabraDavid Schreiber
Nov 19, 2014·Nature Reviews. Urology·Majid ShabbirSuks Minhas
Jun 5, 2014·Expert Opinion on Drug Discovery·Gautum AgarwalPhilippe E Spiess
Feb 18, 2016·Journal of Cancer Research and Therapeutics·Wu-Xia LuoJi-Yan Liu
Jan 24, 2016·Urology·Gregory J DiorioPhilippe E Spiess
Dec 12, 2012·Urologic Oncology·Curtis A PettawayLance Pagliaro
Nov 20, 2012·The Journal of Urology·Michelle J LongprePeter C Black
Aug 1, 2012·Seminars in Oncology Nursing·Jeanne Held-Warmkessel
May 29, 2012·La Presse médicale·Nabil IsmailiHassan Errihani
Nov 29, 2011·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·I SouillacJ Rigaud
Aug 30, 2011·European Urology·Giuseppe Di LorenzoVincenzo Mirone
Jun 18, 2011·The Journal of Urology·Yao ZhuHai-Liang Zhang
Jan 18, 2011·The Journal of Urology·Jack H Mydlo
Sep 11, 2012·BJU International·Giuseppe Di LorenzoSabino De Placido
Nov 15, 2013·BJU International·Steve NicholsonSuks Minhas
Oct 1, 2015·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Annalisa TramaUNKNOWN EUROCARE-5 Working Group:
Feb 25, 2014·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·K J BreenP Sweeney
Apr 29, 2015·Current Problems in Cancer·Pranav SharmaPhilippe E Spiess
Apr 29, 2015·Current Problems in Cancer·Juanita Crook
Apr 30, 2015·Current Problems in Cancer·Lance C Pagliaro
Jun 1, 2015·World Journal of Urology·Kamran Zargar-ShoshtariPhilippe E Spiess
Mar 31, 2015·Urology·Nikolaos Grivas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.